Cleared Traditional

Surgivisio system (K202547) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K202547 · Surgivisio · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2021
Decision
205d
Days
Class 2
Risk

K202547 is an FDA 510(k) clearance for the Surgivisio system. Classified as Interventional Fluoroscopic X-ray System (product code OWB), Class II - Special Controls.

Submitted by Surgivisio (Gieres, FR). The FDA issued a Cleared decision on March 26, 2021 after a review of 205 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Surgivisio devices

Submission Details

510(k) Number K202547 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 02, 2020
Decision Date March 26, 2021
Days to Decision 205 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
98d slower than avg
Panel avg: 107d · This submission: 205d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OWB Interventional Fluoroscopic X-ray System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - OWB Interventional Fluoroscopic X-ray System

All 190
Devices cleared under the same product code (OWB) and FDA review panel - the closest regulatory comparables to K202547.
Trinias
K203535 · Shimadzu Corporation Medical Systems · Apr 2021
Alphenix, INFX-8000C/B, INFX-8000C/S, V9.2
K210900 · Canon Medical Systems Corporation · Apr 2021
StentBoost Mobile
K203623 · Philips India Limited · Apr 2021
Cios Select (VA21) Flat Panel
K210309 · Siemens Medical Solutions USA, Inc. · Mar 2021
Cios Select (VA21) Image Intensifier
K210307 · Siemens Medical Solutions USA, Inc. · Mar 2021
ClarifEye R1.0, ClarifEye Needle
K201743 · Philips Medical Systems Nederlands B.V. · Feb 2021